We've found
2,026
archived clinical trials in
Epilepsy
We've found
2,026
archived clinical trials in
Epilepsy
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Updated: 7/18/2017
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
Updated: 8/28/2017
Evaluation of Efficacy and Safety of Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
Status: Enrolling
Updated: 8/28/2017
Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
Updated: 8/28/2017
Evaluation of Efficacy and Safety of Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.
Updated: 8/28/2017
"Rational Polytherapy" Using Perampanel Dual Therapy Anticonvulsant Combination Treatments of Adults With Refractory Focal Epilepsy : a Pilot Study.
Status: Enrolling
Updated: 8/28/2017
Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.
Updated: 8/28/2017
"Rational Polytherapy" Using Perampanel Dual Therapy Anticonvulsant Combination Treatments of Adults With Refractory Focal Epilepsy : a Pilot Study.
Status: Enrolling
Updated: 8/28/2017
Click here to add this to my saved trials
Brain Infusion of Muscimol to Treat Epilepsy
Updated: 10/5/2017
Trial of Intracerebral Infusion in Patients With Medically Intractable Epilepsy
Status: Enrolling
Updated: 10/5/2017
Brain Infusion of Muscimol to Treat Epilepsy
Updated: 10/5/2017
Trial of Intracerebral Infusion in Patients With Medically Intractable Epilepsy
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
The Role of Serotonin in Seizures
Updated: 10/5/2017
Imaging Serotoninergic Neurotransmission in Epilepsy
Status: Enrolling
Updated: 10/5/2017
The Role of Serotonin in Seizures
Updated: 10/5/2017
Imaging Serotoninergic Neurotransmission in Epilepsy
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy
Updated: 10/5/2017
Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy
Status: Enrolling
Updated: 10/5/2017
Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy
Updated: 10/5/2017
Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Brain Dynamics in Different Stages of Arousal and Anesthesia
Updated: 11/2/2017
Brain Dynamics in Different Stages of Arousal and Anesthesia
Status: Enrolling
Updated: 11/2/2017
Brain Dynamics in Different Stages of Arousal and Anesthesia
Updated: 11/2/2017
Brain Dynamics in Different Stages of Arousal and Anesthesia
Status: Enrolling
Updated: 11/2/2017
Click here to add this to my saved trials
Depression and Health Outcomes in Refractory Epilepsy
Updated: 11/2/2017
Depression and Health Outcomes in Refractory Epilepsy
Status: Enrolling
Updated: 11/2/2017
Depression and Health Outcomes in Refractory Epilepsy
Updated: 11/2/2017
Depression and Health Outcomes in Refractory Epilepsy
Status: Enrolling
Updated: 11/2/2017
Click here to add this to my saved trials
Depression and Health Outcomes in Refractory Epilepsy
Updated: 11/2/2017
Depression and Health Outcomes in Refractory Epilepsy
Status: Enrolling
Updated: 11/2/2017
Depression and Health Outcomes in Refractory Epilepsy
Updated: 11/2/2017
Depression and Health Outcomes in Refractory Epilepsy
Status: Enrolling
Updated: 11/2/2017
Click here to add this to my saved trials
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Updated: 11/9/2017
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Updated: 11/9/2017
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Click here to add this to my saved trials
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Updated: 11/9/2017
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Updated: 11/9/2017
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Click here to add this to my saved trials
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Updated: 11/9/2017
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Updated: 11/9/2017
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Click here to add this to my saved trials
Tolerability and Efficacy of Depakote-extended Release in the Elderly
Updated: 12/5/2017
Tolerability and Efficacy of Depakote-ER in the Elderly
Status: Enrolling
Updated: 12/5/2017
Tolerability and Efficacy of Depakote-extended Release in the Elderly
Updated: 12/5/2017
Tolerability and Efficacy of Depakote-ER in the Elderly
Status: Enrolling
Updated: 12/5/2017
Click here to add this to my saved trials
The Management of Postoperative Craniotomy Pain in Pediatric Patients
Updated: 12/7/2017
The Management of Postoperative Craniotomy Pain in Pediatric Patients: A Prospective Cohort Study
Status: Enrolling
Updated: 12/7/2017
The Management of Postoperative Craniotomy Pain in Pediatric Patients
Updated: 12/7/2017
The Management of Postoperative Craniotomy Pain in Pediatric Patients: A Prospective Cohort Study
Status: Enrolling
Updated: 12/7/2017
Click here to add this to my saved trials
The Management of Postoperative Craniotomy Pain in Pediatric Patients
Updated: 12/7/2017
The Management of Postoperative Craniotomy Pain in Pediatric Patients: A Prospective Cohort Study
Status: Enrolling
Updated: 12/7/2017
The Management of Postoperative Craniotomy Pain in Pediatric Patients
Updated: 12/7/2017
The Management of Postoperative Craniotomy Pain in Pediatric Patients: A Prospective Cohort Study
Status: Enrolling
Updated: 12/7/2017
Click here to add this to my saved trials
The Management of Postoperative Craniotomy Pain in Pediatric Patients
Updated: 12/7/2017
The Management of Postoperative Craniotomy Pain in Pediatric Patients: A Prospective Cohort Study
Status: Enrolling
Updated: 12/7/2017
The Management of Postoperative Craniotomy Pain in Pediatric Patients
Updated: 12/7/2017
The Management of Postoperative Craniotomy Pain in Pediatric Patients: A Prospective Cohort Study
Status: Enrolling
Updated: 12/7/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Updated: 12/14/2017
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Click here to add this to my saved trials